Brief: Anavex Announces Issuance Of New U.S. Intellectual Property Compositions Patent For Anavex®2-73 (Blarcamesine)
01/06/2023 12:31
June 1 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX ANNOUNCES ISSUANCE OF NEW U.S. INTELLECTUAL
PROPERTY
COMPOSITIONS PATENT FOR ANAVEX®2-73 (BLARCAMESINE)
* ANAVEX LIFE SCIENCES CORP - PATENT WILL BE EXPECTED TO
REMAIN IN
FORCE AT LEAST UNTIL OCTOBER 2036, NOT INCLUDING ANY PATENT TERM
EXTENSIONS
Source text for Eikon: ID:nGNX69ZH1v
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board